Prospective, Randomized, Controlled, Multicentre, Open Study Releas of Paclitaxel during PTA versus PTA alone for the treatment of de-novo occluded, stenotic or reoccluded, restenotic superficial femoral (SFA) or popliteal arteries. - FREERIDE-STUDY

Eurocor GmbH0 sites15 target enrollmentTBD

Conditionsnarrowing of the bloodvessel stenosis 10003216

Overview

Phase: Phase 4
Intervention: Not specified
Conditions: narrowing of the bloodvessel
Sponsor: Eurocor GmbH
Enrollment: 15
Status: Withdrawn
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

TBD

End Date

TBD

Last Updated

2 years ago

Study Type

Interventional

Investigators

Sponsor

Eurocor GmbH

Eligibility Criteria

Inclusion Criteria

•Patients with symptomatic ischemia, requiring treatment of SFA or popliteal artery

Exclusion Criteria

•Pregnancy, aneurisma disease of the abdominal aorta, iliac or popliteal arteries, contraindication for anti platelet therapy, stroke\<3months, prior surgery target lesion,

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed

Not Applicable

Prospective, multicenter, randomized, controlled, single-blind other clinical trial. What is the efficacy of pelvic floor biofeedback training with ACTICORE1® for stress incontinence?N39.3Stress incontinence

DRKS00027319ACTICORE GmbH124

Not yet recruiting

Not Applicable

Prospective, multicenter, randomized, controlled, single-blind other clinical trial. What is the efficacy of app-based biofeedback training with ACTICORE1® for female stress incontinence?N39.3Stress incontinence

DRKS00033971ACTICORE GmbH262

Active, not recruiting

Not Applicable

Prospektive, randomized, controlled, multicentre, partly double blind study to compare Disci/Rhus toxicodendron comp., placebo and waiting list in patients with chronic low back pain.chronic low back pain (chronic local or pseudoradiculaere low back pain due to e.g. degenerative basic illness).

EUCTR2006-006390-24-DEWALA Heilmittel GmbH

Recruiting

Not Applicable

Prospective, randomized, controlled, multicenter, operative study to evaluate the role of intraoperative sonography compared to the preoperative wire localization in the treatment of non-palpable breast cancerC50Malignant neoplasm of breast

DRKS00010174niversitätsfrauenklinik230

Active, not recruiting

Phase 1

Multi-center, prospective, controlled, randomized, single-blinded study to evaluate the efficacy of vibrotactile neuro-feedback additionally to intake of Ginkgo biloba special extract EGb 761® for the treament of presby vertigo.Presby VertigoMedDRA version: 20.0 Level: PT Classification code 10047340 Term: Vertigo System Organ Class: 10013993 - Ear and labyrinth disordersTherapeutic area: Diseases [C] - Ear, nose and throat diseases [C09]

EUCTR2014-000303-28-DEDr. Willmar Schwabe GmbH & Co. KG120